1 Study Coverage
1.1 Tacrolimus Product Introduction
1.2 Global Tacrolimus Outlook 2017 VS 2022 VS 2028
1.2.1 Global Tacrolimus Sales in US$ Million for the Year 2017-2028
1.2.2 Global Tacrolimus Sales in Volume for the Year 2017-2028
1.3 United States Tacrolimus Outlook 2017 VS 2022 VS 2028
1.3.1 United States Tacrolimus Sales in US$ Million for the Year 2017-2028
1.3.2 United States Tacrolimus Sales in Volume for the Year 2017-2028
1.4 Tacrolimus Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Tacrolimus in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Tacrolimus Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Tacrolimus Market Dynamics
1.5.1 Tacrolimus Industry Trends
1.5.2 Tacrolimus Market Drivers
1.5.3 Tacrolimus Market Challenges
1.5.4 Tacrolimus Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Tacrolimus Market Segment by Type
2.1.1 Tacrolimus Capsules
2.1.2 Tacrolimus Ointment
2.1.3 Tacrolimus Injection
2.2 Global Tacrolimus Market Size by Type
2.2.1 Global Tacrolimus Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Tacrolimus Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Tacrolimus Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Tacrolimus Market Size by Type
2.3.1 United States Tacrolimus Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Tacrolimus Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Tacrolimus Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Tacrolimus Market Segment by Application
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Other
3.2 Global Tacrolimus Market Size by Application
3.2.1 Global Tacrolimus Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Tacrolimus Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Tacrolimus Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Tacrolimus Market Size by Application
3.3.1 United States Tacrolimus Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Tacrolimus Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Tacrolimus Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Tacrolimus Competitor Landscape by Company
4.1 Global Tacrolimus Market Size by Company
4.1.1 Top Global Tacrolimus Manufacturers Ranked by Revenue (2021)
4.1.2 Global Tacrolimus Revenue by Manufacturer (2017-2022)
4.1.3 Global Tacrolimus Sales by Manufacturer (2017-2022)
4.1.4 Global Tacrolimus Price by Manufacturer (2017-2022)
4.2 Global Tacrolimus Concentration Ratio (CR)
4.2.1 Tacrolimus Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Tacrolimus in 2021
4.2.3 Global Tacrolimus Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Tacrolimus Manufacturing Base Distribution, Product Type
4.3.1 Global Tacrolimus Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Tacrolimus Product Type
4.3.3 Date of International Manufacturers Enter into Tacrolimus Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Tacrolimus Market Size by Company
4.5.1 Top Tacrolimus Players in United States, Ranked by Revenue (2021)
4.5.2 United States Tacrolimus Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Tacrolimus Sales by Players (2020, 2021 & 2022)
5 Global Tacrolimus Market Size by Region
5.1 Global Tacrolimus Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Tacrolimus Market Size in Volume by Region (2017-2028)
5.2.1 Global Tacrolimus Sales in Volume by Region: 2017-2022
5.2.2 Global Tacrolimus Sales in Volume Forecast by Region (2023-2028)
5.3 Global Tacrolimus Market Size in Value by Region (2017-2028)
5.3.1 Global Tacrolimus Sales in Value by Region: 2017-2022
5.3.2 Global Tacrolimus Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Tacrolimus Market Size YoY Growth 2017-2028
6.1.2 North America Tacrolimus Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Tacrolimus Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Tacrolimus Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Tacrolimus Market Size YoY Growth 2017-2028
6.3.2 Europe Tacrolimus Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Tacrolimus Market Size YoY Growth 2017-2028
6.4.2 Latin America Tacrolimus Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Tacrolimus Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Tacrolimus Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 GSK
7.1.1 GSK Corporation Information
7.1.2 GSK Description and Business Overview
7.1.3 GSK Tacrolimus Sales, Revenue and Gross Margin (2017-2022)
7.1.4 GSK Tacrolimus Products Offered
7.1.5 GSK Recent Development
7.2 Abbott
7.2.1 Abbott Corporation Information
7.2.2 Abbott Description and Business Overview
7.2.3 Abbott Tacrolimus Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Abbott Tacrolimus Products Offered
7.2.5 Abbott Recent Development
7.3 Roche Pharma
7.3.1 Roche Pharma Corporation Information
7.3.2 Roche Pharma Description and Business Overview
7.3.3 Roche Pharma Tacrolimus Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Roche Pharma Tacrolimus Products Offered
7.3.5 Roche Pharma Recent Development
7.4 Novartis
7.4.1 Novartis Corporation Information
7.4.2 Novartis Description and Business Overview
7.4.3 Novartis Tacrolimus Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Novartis Tacrolimus Products Offered
7.4.5 Novartis Recent Development
7.5 Mylan
7.5.1 Mylan Corporation Information
7.5.2 Mylan Description and Business Overview
7.5.3 Mylan Tacrolimus Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Mylan Tacrolimus Products Offered
7.5.5 Mylan Recent Development
7.6 Squibb
7.6.1 Squibb Corporation Information
7.6.2 Squibb Description and Business Overview
7.6.3 Squibb Tacrolimus Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Squibb Tacrolimus Products Offered
7.6.5 Squibb Recent Development
7.7 Astellas
7.7.1 Astellas Corporation Information
7.7.2 Astellas Description and Business Overview
7.7.3 Astellas Tacrolimus Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Astellas Tacrolimus Products Offered
7.7.5 Astellas Recent Development
7.8 Aarti Group
7.8.1 Aarti Group Corporation Information
7.8.2 Aarti Group Description and Business Overview
7.8.3 Aarti Group Tacrolimus Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Aarti Group Tacrolimus Products Offered
7.8.5 Aarti Group Recent Development
7.9 Takeda
7.9.1 Takeda Corporation Information
7.9.2 Takeda Description and Business Overview
7.9.3 Takeda Tacrolimus Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Takeda Tacrolimus Products Offered
7.9.5 Takeda Recent Development
7.10 Huapont Pharma
7.10.1 Huapont Pharma Corporation Information
7.10.2 Huapont Pharma Description and Business Overview
7.10.3 Huapont Pharma Tacrolimus Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Huapont Pharma Tacrolimus Products Offered
7.10.5 Huapont Pharma Recent Development
7.11 Senju Pharmaceutical
7.11.1 Senju Pharmaceutical Corporation Information
7.11.2 Senju Pharmaceutical Description and Business Overview
7.11.3 Senju Pharmaceutical Tacrolimus Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Senju Pharmaceutical Tacrolimus Products Offered
7.11.5 Senju Pharmaceutical Recent Development
7.12 Guike Pharmaceutical
7.12.1 Guike Pharmaceutical Corporation Information
7.12.2 Guike Pharmaceutical Description and Business Overview
7.12.3 Guike Pharmaceutical Tacrolimus Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Guike Pharmaceutical Products Offered
7.12.5 Guike Pharmaceutical Recent Development
7.13 Tecoland
7.13.1 Tecoland Corporation Information
7.13.2 Tecoland Description and Business Overview
7.13.3 Tecoland Tacrolimus Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Tecoland Products Offered
7.13.5 Tecoland Recent Development
7.14 Sandoz
7.14.1 Sandoz Corporation Information
7.14.2 Sandoz Description and Business Overview
7.14.3 Sandoz Tacrolimus Sales, Revenue and Gross Margin (2017-2022)
7.14.4 Sandoz Products Offered
7.14.5 Sandoz Recent Development
7.15 ScinoPharm
7.15.1 ScinoPharm Corporation Information
7.15.2 ScinoPharm Description and Business Overview
7.15.3 ScinoPharm Tacrolimus Sales, Revenue and Gross Margin (2017-2022)
7.15.4 ScinoPharm Products Offered
7.15.5 ScinoPharm Recent Development
7.16 RPG Life Science
7.16.1 RPG Life Science Corporation Information
7.16.2 RPG Life Science Description and Business Overview
7.16.3 RPG Life Science Tacrolimus Sales, Revenue and Gross Margin (2017-2022)
7.16.4 RPG Life Science Products Offered
7.16.5 RPG Life Science Recent Development
7.17 Suzhou Pharmaceutical Technology
7.17.1 Suzhou Pharmaceutical Technology Corporation Information
7.17.2 Suzhou Pharmaceutical Technology Description and Business Overview
7.17.3 Suzhou Pharmaceutical Technology Tacrolimus Sales, Revenue and Gross Margin (2017-2022)
7.17.4 Suzhou Pharmaceutical Technology Products Offered
7.17.5 Suzhou Pharmaceutical Technology Recent Development
7.18 Accura Pharmaceuticals
7.18.1 Accura Pharmaceuticals Corporation Information
7.18.2 Accura Pharmaceuticals Description and Business Overview
7.18.3 Accura Pharmaceuticals Tacrolimus Sales, Revenue and Gross Margin (2017-2022)
7.18.4 Accura Pharmaceuticals Products Offered
7.18.5 Accura Pharmaceuticals Recent Development
7.19 Fujisawa Pharmaceutical
7.19.1 Fujisawa Pharmaceutical Corporation Information
7.19.2 Fujisawa Pharmaceutical Description and Business Overview
7.19.3 Fujisawa Pharmaceutical Tacrolimus Sales, Revenue and Gross Margin (2017-2022)
7.19.4 Fujisawa Pharmaceutical Products Offered
7.19.5 Fujisawa Pharmaceutical Recent Development
7.20 Sichuan Med-Shine Pharmaceutical
7.20.1 Sichuan Med-Shine Pharmaceutical Corporation Information
7.20.2 Sichuan Med-Shine Pharmaceutical Description and Business Overview
7.20.3 Sichuan Med-Shine Pharmaceutical Tacrolimus Sales, Revenue and Gross Margin (2017-2022)
7.20.4 Sichuan Med-Shine Pharmaceutical Products Offered
7.20.5 Sichuan Med-Shine Pharmaceutical Recent Development
7.21 Sinopharm Chuankang Pharmaceutical
7.21.1 Sinopharm Chuankang Pharmaceutical Corporation Information
7.21.2 Sinopharm Chuankang Pharmaceutical Description and Business Overview
7.21.3 Sinopharm Chuankang Pharmaceutical Tacrolimus Sales, Revenue and Gross Margin (2017-2022)
7.21.4 Sinopharm Chuankang Pharmaceutical Products Offered
7.21.5 Sinopharm Chuankang Pharmaceutical Recent Development
7.22 Yamanouchi Pharmaceutical
7.22.1 Yamanouchi Pharmaceutical Corporation Information
7.22.2 Yamanouchi Pharmaceutical Description and Business Overview
7.22.3 Yamanouchi Pharmaceutical Tacrolimus Sales, Revenue and Gross Margin (2017-2022)
7.22.4 Yamanouchi Pharmaceutical Products Offered
7.22.5 Yamanouchi Pharmaceutical Recent Development
7.23 Zhongmei Huadong Pharmaceutical
7.23.1 Zhongmei Huadong Pharmaceutical Corporation Information
7.23.2 Zhongmei Huadong Pharmaceutical Description and Business Overview
7.23.3 Zhongmei Huadong Pharmaceutical Tacrolimus Sales, Revenue and Gross Margin (2017-2022)
7.23.4 Zhongmei Huadong Pharmaceutical Products Offered
7.23.5 Zhongmei Huadong Pharmaceutical Recent Development
7.24 Hisun Pharmaceutical
7.24.1 Hisun Pharmaceutical Corporation Information
7.24.2 Hisun Pharmaceutical Description and Business Overview
7.24.3 Hisun Pharmaceutical Tacrolimus Sales, Revenue and Gross Margin (2017-2022)
7.24.4 Hisun Pharmaceutical Products Offered
7.24.5 Hisun Pharmaceutical Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Tacrolimus Industry Chain Analysis
8.2 Tacrolimus Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Tacrolimus Distributors
8.3 Tacrolimus Production Mode & Process
8.4 Tacrolimus Sales and Marketing
8.4.1 Tacrolimus Sales Channels
8.4.2 Tacrolimus Distributors
8.5 Tacrolimus Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Tacrolimus CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Tacrolimus Market Trends
Table 3. Tacrolimus Market Drivers
Table 4. Tacrolimus Market Challenges
Table 5. Tacrolimus Market Restraints
Table 6. Global Tacrolimus Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Tacrolimus Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Tacrolimus Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Tacrolimus Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Tacrolimus Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Tacrolimus Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Tacrolimus Revenue Share by Manufacturer, 2017-2022
Table 13. Global Tacrolimus Sales by Manufacturer, (K MT), 2017-2022
Table 14. Global Tacrolimus Sales Share by Manufacturer, 2017-2022
Table 15. Global Tacrolimus Price by Manufacturer (2017-2022) & (USD/MT)
Table 16. Global Tacrolimus Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Tacrolimus by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tacrolimus as of 2021)
Table 18. Top Players of Tacrolimus in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Tacrolimus Product Type
Table 20. Date of International Manufacturers Enter into Tacrolimus Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Tacrolimus Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Tacrolimus Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Tacrolimus Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Tacrolimus Sales by Players, (K MT), 2020, 2021 & 2022
Table 26. United States Tacrolimus Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Tacrolimus Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Tacrolimus Sales in Volume by Region (2017-2022) & (K MT)
Table 29. Global Tacrolimus Sales in Volume Forecast by Region (2023-2028) & (K MT)
Table 30. Global Tacrolimus Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Tacrolimus Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Tacrolimus Sales in Volume by Country (2017-2028) & (K MT)
Table 33. North America Tacrolimus Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Tacrolimus Sales in Volume by Region (2017-2028) & (K MT)
Table 35. Asia Pacific Tacrolimus Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Tacrolimus Sales in Volume by Country (2017-2028) & (K MT)
Table 37. Europe Tacrolimus Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Tacrolimus Sales in Volume by Country (2017-2028) & (K MT)
Table 39. Latin Americaa Tacrolimus Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Tacrolimus Sales in Volume by Country (2017-2028) & (K MT)
Table 41. Middle East and Africa Tacrolimus Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. GSK Corporation Information
Table 43. GSK Description and Business Overview
Table 44. GSK Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 45. GSK Tacrolimus Product
Table 46. GSK Recent Development
Table 47. Abbott Corporation Information
Table 48. Abbott Description and Business Overview
Table 49. Abbott Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 50. Abbott Product
Table 51. Abbott Recent Development
Table 52. Roche Pharma Corporation Information
Table 53. Roche Pharma Description and Business Overview
Table 54. Roche Pharma Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 55. Roche Pharma Product
Table 56. Roche Pharma Recent Development
Table 57. Novartis Corporation Information
Table 58. Novartis Description and Business Overview
Table 59. Novartis Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 60. Novartis Product
Table 61. Novartis Recent Development
Table 62. Mylan Corporation Information
Table 63. Mylan Description and Business Overview
Table 64. Mylan Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 65. Mylan Product
Table 66. Mylan Recent Development
Table 67. Squibb Corporation Information
Table 68. Squibb Description and Business Overview
Table 69. Squibb Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 70. Squibb Product
Table 71. Squibb Recent Development
Table 72. Astellas Corporation Information
Table 73. Astellas Description and Business Overview
Table 74. Astellas Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 75. Astellas Product
Table 76. Astellas Recent Development
Table 77. Aarti Group Corporation Information
Table 78. Aarti Group Description and Business Overview
Table 79. Aarti Group Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 80. Aarti Group Product
Table 81. Aarti Group Recent Development
Table 82. Takeda Corporation Information
Table 83. Takeda Description and Business Overview
Table 84. Takeda Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 85. Takeda Product
Table 86. Takeda Recent Development
Table 87. Huapont Pharma Corporation Information
Table 88. Huapont Pharma Description and Business Overview
Table 89. Huapont Pharma Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 90. Huapont Pharma Product
Table 91. Huapont Pharma Recent Development
Table 92. Senju Pharmaceutical Corporation Information
Table 93. Senju Pharmaceutical Description and Business Overview
Table 94. Senju Pharmaceutical Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 95. Senju Pharmaceutical Product
Table 96. Senju Pharmaceutical Recent Development
Table 97. Guike Pharmaceutical Corporation Information
Table 98. Guike Pharmaceutical Description and Business Overview
Table 99. Guike Pharmaceutical Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 100. Guike Pharmaceutical Product
Table 101. Guike Pharmaceutical Recent Development
Table 102. Tecoland Corporation Information
Table 103. Tecoland Description and Business Overview
Table 104. Tecoland Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 105. Tecoland Product
Table 106. Tecoland Recent Development
Table 107. Sandoz Corporation Information
Table 108. Sandoz Description and Business Overview
Table 109. Sandoz Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 110. Sandoz Product
Table 111. Sandoz Recent Development
Table 112. ScinoPharm Corporation Information
Table 113. ScinoPharm Description and Business Overview
Table 114. ScinoPharm Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 115. ScinoPharm Product
Table 116. ScinoPharm Recent Development
Table 117. RPG Life Science Corporation Information
Table 118. RPG Life Science Description and Business Overview
Table 119. RPG Life Science Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 120. RPG Life Science Product
Table 121. RPG Life Science Recent Development
Table 122. Suzhou Pharmaceutical Technology Corporation Information
Table 123. Suzhou Pharmaceutical Technology Description and Business Overview
Table 124. Suzhou Pharmaceutical Technology Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 125. Suzhou Pharmaceutical Technology Product
Table 126. Suzhou Pharmaceutical Technology Recent Development
Table 127. Accura Pharmaceuticals Corporation Information
Table 128. Accura Pharmaceuticals Description and Business Overview
Table 129. Accura Pharmaceuticals Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 130. Accura Pharmaceuticals Product
Table 131. Accura Pharmaceuticals Recent Development
Table 132. Fujisawa Pharmaceutical Corporation Information
Table 133. Fujisawa Pharmaceutical Description and Business Overview
Table 134. Fujisawa Pharmaceutical Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 135. Fujisawa Pharmaceutical Product
Table 136. Fujisawa Pharmaceutical Recent Development
Table 137. Sichuan Med-Shine Pharmaceutical Corporation Information
Table 138. Sichuan Med-Shine Pharmaceutical Description and Business Overview
Table 139. Sichuan Med-Shine Pharmaceutical Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 140. Sichuan Med-Shine Pharmaceutical Product
Table 141. Sichuan Med-Shine Pharmaceutical Recent Development
Table 142. Sinopharm Chuankang Pharmaceutical Corporation Information
Table 143. Sinopharm Chuankang Pharmaceutical Description and Business Overview
Table 144. Sinopharm Chuankang Pharmaceutical Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 145. Sinopharm Chuankang Pharmaceutical Product
Table 146. Sinopharm Chuankang Pharmaceutical Recent Development
Table 147. Yamanouchi Pharmaceutical Corporation Information
Table 148. Yamanouchi Pharmaceutical Description and Business Overview
Table 149. Yamanouchi Pharmaceutical Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 150. Yamanouchi Pharmaceutical Product
Table 151. Yamanouchi Pharmaceutical Recent Development
Table 152. Zhongmei Huadong Pharmaceutical Corporation Information
Table 153. Zhongmei Huadong Pharmaceutical Description and Business Overview
Table 154. Zhongmei Huadong Pharmaceutical Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 155. Zhongmei Huadong Pharmaceutical Product
Table 156. Zhongmei Huadong Pharmaceutical Recent Development
Table 157. Hisun Pharmaceutical Corporation Information
Table 158. Hisun Pharmaceutical Description and Business Overview
Table 159. Hisun Pharmaceutical Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 160. Hisun Pharmaceutical Product
Table 161. Hisun Pharmaceutical Recent Development
Table 162. Key Raw Materials Lists
Table 163. Raw Materials Key Suppliers Lists
Table 164. Tacrolimus Customers List
Table 165. Tacrolimus Distributors List
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
List of Figures
Figure 1. Tacrolimus Product Picture
Figure 2. Global Tacrolimus Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Tacrolimus Market Size 2017-2028 (US$ Million)
Figure 4. Global Tacrolimus Sales 2017-2028 (K MT)
Figure 5. United States Tacrolimus Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Tacrolimus Market Size 2017-2028 (US$ Million)
Figure 7. United States Tacrolimus Sales 2017-2028 (K MT)
Figure 8. United States Tacrolimus Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Tacrolimus Market Share in Global, in Volume (K MT) 2017-2028
Figure 10. Tacrolimus Report Years Considered
Figure 11. Product Picture of Tacrolimus Capsules
Figure 12. Product Picture of Tacrolimus Ointment
Figure 13. Product Picture of Tacrolimus Injection
Figure 14. Global Tacrolimus Market Share by Type in 2022 & 2028
Figure 15. Global Tacrolimus Sales in Value by Type (2017-2028) & (US$ Million)
Figure 16. Global Tacrolimus Sales Market Share in Value by Type (2017-2028)
Figure 17. Global Tacrolimus Sales by Type (2017-2028) & (K MT)
Figure 18. Global Tacrolimus Sales Market Share in Volume by Type (2017-2028)
Figure 19. Global Tacrolimus Price by Type (2017-2028) & (USD/MT)
Figure 20. United States Tacrolimus Market Share by Type in 2022 & 2028
Figure 21. United States Tacrolimus Sales in Value by Type (2017-2028) & (US$ Million)
Figure 22. United States Tacrolimus Sales Market Share in Value by Type (2017-2028)
Figure 23. United States Tacrolimus Sales by Type (2017-2028) & (K MT)
Figure 24. United States Tacrolimus Sales Market Share in Volume by Type (2017-2028)
Figure 25. United States Tacrolimus Price by Type (2017-2028) & (USD/MT)
Figure 26. Product Picture of Hospitals
Figure 27. Product Picture of Clinics
Figure 28. Product Picture of Other
Figure 29. Global Tacrolimus Market Share by Application in 2022 & 2028
Figure 30. Global Tacrolimus Sales in Value by Application (2017-2028) & (US$ Million)
Figure 31. Global Tacrolimus Sales Market Share in Value by Application (2017-2028)
Figure 32. Global Tacrolimus Sales by Application (2017-2028) & (K MT)
Figure 33. Global Tacrolimus Sales Market Share in Volume by Application (2017-2028)
Figure 34. Global Tacrolimus Price by Application (2017-2028) & (USD/MT)
Figure 35. United States Tacrolimus Market Share by Application in 2022 & 2028
Figure 36. United States Tacrolimus Sales in Value by Application (2017-2028) & (US$ Million)
Figure 37. United States Tacrolimus Sales Market Share in Value by Application (2017-2028)
Figure 38. United States Tacrolimus Sales by Application (2017-2028) & (K MT)
Figure 39. United States Tacrolimus Sales Market Share in Volume by Application (2017-2028)
Figure 40. United States Tacrolimus Price by Application (2017-2028) & (USD/MT)
Figure 41. North America Tacrolimus Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 42. North America Tacrolimus Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 43. U.S. Tacrolimus Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 44. Canada Tacrolimus Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 45. Europe Tacrolimus Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 46. Europe Tacrolimus Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 47. Germany Tacrolimus Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. France Tacrolimus Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. U.K. Tacrolimus Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Italy Tacrolimus Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Russia Tacrolimus Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. Asia-Pacific Tacrolimus Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 53. Asia-Pacific Tacrolimus Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 54. China Tacrolimus Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. Japan Tacrolimus Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. South Korea Tacrolimus Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. India Tacrolimus Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Australia Tacrolimus Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Taiwan Tacrolimus Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Indonesia Tacrolimus Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Thailand Tacrolimus Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Malaysia Tacrolimus Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Philippines Tacrolimus Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Latin America Tacrolimus Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 65. Latin America Tacrolimus Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 66. Mexico Tacrolimus Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Brazil Tacrolimus Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Argentina Tacrolimus Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 69. Middle East & Africa Tacrolimus Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 70. Middle East & Africa Tacrolimus Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 71. Turkey Tacrolimus Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. Saudi Arabia Tacrolimus Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. UAE Tacrolimus Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 74. Tacrolimus Value Chain
Figure 75. Tacrolimus Production Process
Figure 76. Channels of Distribution
Figure 77. Distributors Profiles
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
GSK Abbott Roche Pharma Novartis Mylan Squibb Astellas Aarti Group Takeda Huapont Pharma Senju Pharmaceutical Guike Pharmaceutical Tecoland Sandoz ScinoPharm RPG Life Science Suzhou Pharmaceutical Technology Accura Pharmaceuticals Fujisawa Pharmaceutical Sichuan Med-Shine Pharmaceutical Sinopharm Chuankang Pharmaceutical Yamanouchi Pharmaceutical Zhongmei Huadong Pharmaceutical Hisun Pharmaceutical